Controversial issues in comorbidity between epilepsy and autism: Subclinical epileptiform activity and autistic epileptiform regression [дискуссионные вопросы коморбидности аутизма и эпилепсии: субклиническая эпилептиформная активность и аутистический эпилептиформный регресс]

Early childhood autism, or autism spectrum disorders, is an extremely heterogeneous group of conditions that share similar symptoms of dysontogenesis. The most significant comorbidity in patients with autism is epilepsy, which is still associated with a variety of controversies. The present article covers the most controversial aspects of comorbidity between autism and epilepsy, including the impact of psychopharmacotherapy on the risk of epilepsy, clinical significance of epileptiform activity on the electroencephalogram in patients without epilepsy, and criteria for and prevalence of autistic epileptiform regression syndrome. We found that there is still a lack of reliable evidence for the majority of issues related to the combination of autism and epilepsy. We emphasize the need for further studies. We also provide a detailed description of the history, criteria, prevalence, and clinical examples of autistic epileptiform regression syndrome. © 2019 ABV-Press Publishing House. All rights reserved.

Авторы
Kuzmich G.V.1, 2 , Sinelnikova A.N. 3 , Mukhin K.Yu.1
Издательство
ABV-Press Publishing House
Номер выпуска
1
Язык
Русский
Страницы
40-48
Статус
Опубликовано
Том
14
Год
2019
Организации
  • 1 Svt. Luka's Institute of Child Neurology and Epilepsy, 5 Nagornaya St., Troitsk, Moscow, 108840, Russian Federation
  • 2 Scientific and Practical Center for Mental Health of Children and Adolescents named after G.E. Sukhareva, Moscow City Department of Health, 21A 5th Donskoy proezd, Moscow, 119334, Russian Federation
  • 3 Medical Institute, Peoples' Friendship University of Russia, 6 Miklukho-Maklaya St., Moscow, 117198, Russian Federation
Ключевые слова
Autism; Autism spectrum disorders; Autistic epileptiform regression; Epilepsy; Psychopharmacotherapy; Subclinical epileptiform activity
Дата создания
24.12.2019
Дата изменения
24.12.2019
Постоянная ссылка
https://repository.rudn.ru/ru/records/article/record/55510/
Поделиться

Другие записи

Devyatov A.G., Lapshin G.S., Babaeva E.Y., Motina E.A., Zvezdina E.V., Vandishev V.V.
Фармация и фармакология. Пятигорский медико-фармацевтический институт - филиал федерального бюджетного образовательного учреждения высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации. Том 7. 2019. С. 120-128